(Press-News.org) According to the United Nations, the proportion of people aged over 65 now outnumber children younger than 5. The enormous growth in the elderly population is posing a socioeconomic challenge to societies worldwide, and necessitates new sweeping interventions for age-associated diseases. This year we have an incredibly exciting program with global thought-leaders sharing their latest insights into aging and how we target the aging process ensuring everyone lives a healthier and longer life. Welcome to the 11th Aging Research and Drug Discovery Meeting.
This year, ARDD is proud to be a partner of XPRIZE Healthspan, a 7-year, $101 million global competition to revolutionize the way we approach human aging. Competing teams will develop and test therapeutics that restore muscle, cognition, and immune function by a minimum of 10 years with a goal of 20 years. Highlighting this collaboration, XPRIZE Healthspan will host its first XPRIZE Healthspan Team Summit at the 11th ARDD. The event underscores a shared commitment between ARDD and XPRIZE to fostering advancements in health and longevity, signaling an important milestone in efforts to enable everyone to live healthier and longer lives through extended healthspan.
“XPRIZE Healthspan is setting out to revolutionize the way we think about and treat aging through the development of therapeutics that target biological aging rather than disease,” said Jamie Justice, Ph.D., Executive Director of XPRIZE Healthspan, XPRIZE. “In order to accomplish this, we need partners like ARDD to help bring together global thought leaders that can create a future where healthy aging is made possible for everyone.”
“I’m extremely excited about this year's ARDD. We have a stellar academic lineup and an incredibly strong presence from leading companies in the aging field. This year the presence of pharma companies including Lilly, Lundbeck, Novartis, Regeneron and many others have been strengthened and we are super excited that XPRIZE will host their XPRIZE Healthspan Team Summit at ARDD. We are continuing to offer 3 travel grants for young scholars to attend ARDD and give generous poster awards for the top poster presentations. This edition of ARDD is shaping up to be a fantastic conference. Tickets are limited so we encourage everyone to sign up early to secure a spot in Copenhagen. I very much look forward to seeing old and new friends here in Copenhagen.” said Morten Scheibye-Knudsen, MD, Ph.D., University of Copenhagen.
“I'm genuinely thrilled about the upcoming ARDD conference this year! Building on the incredible success and full bookings of last year's event, this year promises again unique opportunities to connect with brilliant minds, fostering collaboration and showcasing groundbreaking research. What makes this year even more special is that we are eagerly welcoming even more pharmaceutical companies to join us on this journey. But that's not all – we're proud to announce our collaboration with XPRIZE. So, mark your calendar and join us at ARDD2024.” said Daniela Bakula, Ph.D., University of Copenhagen.
“Thanks to the tireless and disciplined efforts of the University of Copenhagen and specifically professors Scheibye-Knudsen and Bakula, the ARDD has grown to become the largest and most important conference in longevity biotechnology sponsored by over 30 biotechnology startups. The knowledge partner is BCG and executives of top pharma companies and editors of major journals are taking part. Unsurprisingly, the XPRIZE Healthspan, one of the most important initiatives in this industry, decided to host its first Team Summit during the ARDD. Copenhagen has become the epicenter of the global longevity community”, said Alex Zhavoronkov, Ph.D., founder and CEO of Insilico Medicine.
Since 2020, ARDD has been opening with a clinically-oriented Longevity Medicine Day, which has been of great success in terms of attracting physicians and related health care professionals. “The upcoming 5th Longevity Medicine and XPRIZE Healthspan Team Summit at ARDD, marks a significant milestone in the integration of cutting-edge geroscience and AI into clinical practice, with a focus on extending healthspan and reversing biological aging. This collaboration underscores the essential role of physicians and healthcare professionals in translating scientific advancements into tangible medical solutions. As we gather the medical community for this event, we reaffirm our commitment to pushing the boundaries of longevity medicine to improve patient care and outcomes.” said Prof.Dr.Evelyne Bischof, the organizer of the Longevity Medicine Days.
As every year, ARDD will be collaborating with the Longevity Medicine Education Hub at Longevity.Degree, on which Longevity medicine course series are available with CME accreditation for free. The course series will now be expanding and feature a special Longevity Course for Investors.
Three travel grants will be available for junior scholars (up to 2,000 USD each) for the 11th ARDD. In addition to the travel, the grantees will be given short talk slots in the program. To be considered please send an abstract and cover letter to bakula@sund.ku.dk with the subject “Application for travel grant” by June 1. Individuals that have already registered and submitted abstracts will also be eligible and contacted if they are selected.
For further information, images or interviews, please contact:
ardd@pharma.ai
About Aging Research for Drug Discovery Conference
At ARDD, leaders in the aging, longevity, and drug discovery field will describe the latest progress in the molecular, cellular and organismal basis of aging and the search for interventions. Furthermore, the meeting will include opinion leaders in AI to discuss the latest advances of this technology in the biopharmaceutical sector and how this can be applied to interventions. Notably, this year we will have a special day called Longevity Medicine Day, specifically for physicians where the leading-edge knowledge of clinical interventions for healthy longevity will be described. ARRD intends to bridge clinical, academic and commercial research and foster collaborations that will result in practical solutions to one of humanity's most challenging problems: aging. Our quest? To extend the healthy lifespan of everyone on the planet.
About XPRIZE
XPRIZE is an established global leader in designing, launching, and executing large-scale competitions to solve humanity’s greatest challenges. Our unique model democratizes innovation by incentivizing crowd-sourced, scientifically viable solutions to create a more equitable and abundant future for all. Donate, learn more, or join a team at xprize.org.
END
11th ARDD Meeting Announces initial stellar speaker lineup and XPRIZE Healthspan Team Summit
Initial speaker lineup and travel grants revealed for the 11th Aging Research & Drug Discovery Meeting, featuring the XPRIZE Healthspan Team Summit
2024-03-19
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Cell therapy approach harnesses the immune system in a different way to stop cancer
2024-03-19
NOTE TO EDITORS: High-resolution b-roll, soundbites and images are available for download at https://bit.ly/3PfnX5Y
COLUMBUS, Ohio – A new cancer treatment that uses a person’s own immune cells has been approved by the U.S. Food and Drug Administration (FDA) for treating the most dangerous type of skin cancer. Now this form of cellular therapy (tumor-infiltrating lymphocyte – or TIL therapy) is showing promise in advanced lung cancers through clinical trials underway at The Ohio State University Comprehensive Cancer ...
Artificial intelligence algorithms for understanding the determinants of oral health
2024-03-19
Alexandria, VA, USA – A study aiming to use AI and predictive models to forecast the likelihood of permanent tooth loss, as an indicator of overall oral health, based on various behavioral and lifestyle factors was presented at the 102nd General Session of the IADR, which was held in conjunction with the 53rd Annual Meeting of the American Association for Dental, Oral, and Craniofacial Research and the 48th Annual Meeting of the Canadian Association for Dental Research, on March 13-16, 2024, in New Orleans, LA, USA.
The abstract, “Artificial Intelligence Algorithms for Understanding the Determinants of Oral Health” was presented during ...
Predicting oral cancer-related mortality among adults using machine learning approach
2024-03-19
Alexandria, VA, USA – A study aiming to predict oral cancer-related mortality among adults in the United States and identify the predictors of oral cancer-related mortality using the Machine Learning Approach. was presented at the 102nd General Session of the IADR, which was held in conjunction with the 53rd Annual Meeting of the American Association for Dental, Oral, and Craniofacial Research and the 48th Annual Meeting of the Canadian Association for Dental Research, on March 13-16, 2024, in New Orleans, LA, USA.
The abstract, “Predicting Oral Cancer-Related Mortality among Adults Using Machine Learning Approach” was presented ...
Harnessing biomaterial-based FTY720 immunotherapy to accelerate oral wound healing
2024-03-19
Alexandria, VA, USA – A study aiming to deliver Fingolimod (FTY720) loaded polymer scaffolds to enhance oral wound healing by modulating pro-regenerative immune cell migration associated with improved vascularization and tissue remodeling was presented at the 102nd General Session of the IADR, which was held in conjunction with the 53rd Annual Meeting of the American Association for Dental, Oral, and Craniofacial Research and the 48th Annual Meeting of the Canadian Association for Dental Research, on March 13-16, 2024, in New Orleans, LA, USA.
The abstract, “Harnessing Biomaterial-Based ...
Oral health behaviors associated with mental health disorders
2024-03-19
Alexandria, VA, USA – A study aiming to examine oral hygiene self-care behavior among patients with self-reported mental health disorders was presented at the 102nd General Session of the IADR, which was held in conjunction with the 53rd Annual Meeting of the American Association for Dental, Oral, and Craniofacial Research and the 48th Annual Meeting of the Canadian Association for Dental Research, on March 13-16, 2024, in New Orleans, LA, USA.
The abstract, “Oral Health Behaviors Associated with Mental Health Disorders” was presented during the ...
Researchers develop deep learning model to predict breast cancer
2024-03-19
OAK BROOK, Ill. – Researchers have developed a new, interpretable artificial intelligence (AI) model to predict 5-year breast cancer risk from mammograms, according to a new study published today in Radiology, a journal of the Radiological Society of North America (RSNA).
One in 8 women, or approximately 13% of the female population in the U.S., will develop invasive breast cancer in their lifetime and 1 in 39 women (3%) will die from the disease, according to the American Cancer Society. Breast ...
Social activities can prevent cognitive decline in care facility residents
2024-03-19
Social activities such as interactions with others and participation in organised events can prevent cognitive decline in long-term care facility. Research from Amsterdam UMC, carried out among 3600 patients in 42 Dutch and Belgian care homes, shows that participation in social activities offers a protective effect for those with no, or little, cognitive impairment. These results are published today in the Journal of Alzheimer's Disease.
"Cognitive decline in long-term care residents is relatively common, a Canadian study showed that almost a quarter of residents cognitively declined after a year of residency," ...
BU study finds coping is related to longevity in older men
2024-03-19
(Boston)—Coping is defined as cognitive and behavioral efforts to manage stressors that people believe exceed their ability and resources to respond to effectively. While previous research has linked stressor characteristics, such as the type of event and its duration, and how stressed people feel in response to them, to higher mortality risk, far fewer studies have considered the long-term health consequences of how we manage stressors (coping) in large-scale studies.
In a new study from ...
MRI and lumbar puncture not necessarily required to manage CAR T-cell therapy complications
2024-03-19
(WASHINGTON, March 19, 2024) – Magnetic resonance imaging (MRI) and lumbar puncture (LP) may not always be necessary for diagnosing and managing a serious neurological complication associated with CAR T-cell therapy, according to a new Blood Advances study. Findings further validated the use of the electroencephalogram (EEG) – a noninvasive test measuring electrical activity in the brain – in managing this neurotoxicity.
“When treating patients for CAR T-cell associated toxicities, we typically follow pretty ...
Empty “backpacks” activate the immune system against cancer
2024-03-19
Most of the white blood cells in your body are a type of cell called neutrophils. Despite their high numbers, they are less well understood than other immune cells, in part because they have very short lifespans: an average neutrophil lives for only eight hours. However, recent work has shown that neutrophils are very flexible cells, capable of dialing inflammation up or down, especially in the context of cancer. This makes them attractive targets for immunotherapy, which aims to tweak the immune system to more potently attack disease. But neutrophil-based ...
LAST 30 PRESS RELEASES:
Walking, moving more may lower risk of cardiovascular death for women with cancer history
Intracortical neural interfaces: Advancing technologies for freely moving animals
Post-LLM era: New horizons for AI with knowledge, collaboration, and co-evolution
“Sloshing” from celestial collisions solves mystery of how galactic clusters stay hot
Children poisoned by the synthetic opioid, fentanyl, has risen in the U.S. – eight years of national data shows
USC researchers observe mice may have a form of first aid
VUMC to develop AI technology for therapeutic antibody discovery
Unlocking the hidden proteome: The role of coding circular RNA in cancer
Advancing lung cancer treatment: Understanding the differences between LUAD and LUSC
Study reveals widening heart disease disparities in the US
The role of ubiquitination in cancer stem cell regulation
New insights into LSD1: a key regulator in disease pathogenesis
Vanderbilt lung transplant establishes new record
Revolutionizing cancer treatment: targeting EZH2 for a new era of precision medicine
Metasurface technology offers a compact way to generate multiphoton entanglement
Effort seeks to increase cancer-gene testing in primary care
Acoustofluidics-based method facilitates intracellular nanoparticle delivery
Sulfur bacteria team up to break down organic substances in the seabed
Stretching spider silk makes it stronger
Earth's orbital rhythms link timing of giant eruptions and climate change
Ammonia build-up kills liver cells but can be prevented using existing drug
New technical guidelines pave the way for widespread adoption of methane-reducing feed additives in dairy and livestock
Eradivir announces Phase 2 human challenge study of EV25 in healthy adults infected with influenza
New study finds that tooth size in Otaria byronia reflects historical shifts in population abundance
nTIDE March 2025 Jobs Report: Employment rate for people with disabilities holds steady at new plateau, despite February dip
Breakthrough cardiac regeneration research offers hope for the treatment of ischemic heart failure
Fluoride in drinking water is associated with impaired childhood cognition
New composite structure boosts polypropylene’s low-temperature toughness
While most Americans strongly support civics education in schools, partisan divide on DEI policies and free speech on college campuses remains
Revolutionizing surface science: Visualization of local dielectric properties of surfaces
[Press-News.org] 11th ARDD Meeting Announces initial stellar speaker lineup and XPRIZE Healthspan Team SummitInitial speaker lineup and travel grants revealed for the 11th Aging Research & Drug Discovery Meeting, featuring the XPRIZE Healthspan Team Summit